Kevin H Eng

10PUBLICATIONS
36CO-AUTHORS
Cancer geneticsPredictive and prognostic markersMolecular targetsTumour immunologyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 28, 2026
Correction: Oturkar et al. Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC). Cancers 2022, 14, 1120.

|Oct 14, 2022
Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers.

Emmanuel B Omole, Iqbal Aijaz, James Ellegate

|Mar 10, 2022
Estrogen Receptor-Beta2 (ERβ2)-Mutant p53-FOXM1 Axis: A Novel Driver of Proliferation, Chemoresistance, and Disease Progression in High Grade Serous Ovarian Cancer (HGSOC).

Chetan C Oturkar, Nishant Gandhi, Pramod Rao

|Feb 15, 2022
Loss of MAGEC3 Expression Is Associated with Prognosis in Advanced Ovarian Cancers.

James Ellegate, Michalis Mastri, Emily Isenhart

|Jul 13, 2021
Selective therapeutic strategy for p53-deficient cancer by targeting dysregulation in DNA repair.

Justin Zonneville, Moyi Wang, Mohammed M Alruwaili

|May 15, 2021
Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer.

Tiffany R Emmons, Thejaswini Giridharan, Kelly L Singel

Pageof 2

Frequent Collaborators

2 joint publications

Emese Zsiros

2 joint publications

Austin Miller

2 joint publications

Gokul M Das

2 joint publications

Chetan C Oturkar